Dengue Vaccine Market By Product and Distribution Channel - Global Industry Analysis And Forecast To 2027
Published On : June 2022 Pages : 180 Category: Petrochemicals Report Code : CM063857
Dengue Vaccine Market By Product (CYD-TDV (Dengvaxia)) and Distribution Channel (Online Pharmacies, Hospital Pharmacies, Drug Store, Retail Pharmacies and Other Distribution Channels) - Global Industry Analysis And Forecast To 2027
Industry Outlook
The dengue disease is the mosquito-borne viral disease causing an extreme influenza like disorder and, at times causing the conceivably deadly complexity known as serious dengue. Dengue is the viral disease quickly developing pandemic in numerous parts across the globe. Dengue thrives in the urban poor zones, rural areas and the countryside in addition influences progressively affluent neighborhoods in the subtropical and tropical nations. Therefore, the Dengue Vaccine Market is anticipated to expand and has tremendous scope during the forecast period. The global Dengue Vaccine Market anticipated to flourish in the future by growing at a significantly higher CAGR.
Market Segmentation
By Product the market is segmented into CYD-TDV (Dengvaxia). The product utilization in growing due to increasing number of cases related to dengue for avoiding the spread on the disease.
By Distribution Channel the market is segmented into Online Pharmacies, Hospital Pharmacies, Drug Store, Retail Pharmacies and Other Distribution Channels. The Hospital Pharmacies section is leading the market due to ease of access for the OPD patients for purchasing the medicines and some other factors.
Regional Insights
The North American region is leading the global Dengue Vaccine Market with respect to revenue followed by European region; while the Asia Pacific region is showing growth due to rising cases related to dengue, increasing expenditure on the healthcare industry and few other factors.
Dengue Vaccine Market, By Region
-
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Competitive Analysis
The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and market share of the overall industry.
- Takeda Pharmaceutical Company Ltd.
- Sanofi Pasteur
- Merck & Co., Inc.
- Panacea Biotec
- GlaxoSmithKline plc
- Biological E. Limited
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
o Dengue Vaccine Market, By Product, Estimates and Forecast, 2017-2027 ($Million)
o CYD-TDV (Dengvaxia)
o Dengue Vaccine Market, By Distribution Channel, Estimates and Forecast, 2017-2027 ($Million)
o Online Pharmacies
o Hospital Pharmacies
o Drug Store
o Retail Pharmacies
o Other Distribution Channels
o Dengue Vaccine Market, By Key Players, Estimates and Forecast, 2017-2027 ($Million)
o Takeda Pharmaceutical Company Ltd.
o Sanofi Pasteur
o Merck & Co., Inc.
o Panacea Biotec
o GlaxoSmithKline plc
o Biological E. Limited
o Dengue Vaccine Market, By Region, Estimates and Forecast, 2017-2027 ($Million)
o North America
§ North America Dengue Vaccine Market , By Country
o U.S. Dengue Vaccine Market
o Canada Dengue Vaccine Market
o Mexico Dengue Vaccine Market
o Europe
§ Europe Dengue Vaccine Market , By Country
o Germany Dengue Vaccine Market
o UK Dengue Vaccine Market
o France Dengue Vaccine Market
o Russia Dengue Vaccine Market
o Italy Dengue Vaccine Market
o Rest of Europe Dengue Vaccine Market
o Asia-Pacific
§ Asia-Pacific Dengue Vaccine Market , By Country
o China Dengue Vaccine Market
o Japan Dengue Vaccine Market
o South Korea Dengue Vaccine Market
o India Dengue Vaccine Market
o Southeast Asia Dengue Vaccine Market
o Rest of Asia-Pacific Dengue Vaccine Market
o South America
§ South America Dengue Vaccine Market , By Country
o Brazil Dengue Vaccine Market
o Argentina Dengue Vaccine Market
o Columbia Dengue Vaccine Market
o Rest of South America Dengue Vaccine Market
o Middle East and Africa
§ Middle East and Africa Dengue Vaccine Market , By Country
o Saudi Arabia Dengue Vaccine Market
o UAE Dengue Vaccine Market
o Egypt Dengue Vaccine Market
o Nigeria Dengue Vaccine Market
o South Africa Dengue Vaccine Market
o Rest of MEA Dengue Vaccine Market
Table of Contents:
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Dengue Vaccine Market, By Product
5.1. Introduction
5.2. Global Dengue Vaccine Revenue and Market Share by Product (2017-2027)
5.2.1. Global Dengue Vaccine Revenue and Revenue Share by Product (2017-2027)
5.3. CYD-TDV (Dengvaxia)
5.3.1. Global CYD-TDV (Dengvaxia) Revenue and Growth Rate (2017-2027)
6. Dengue Vaccine Market, By Distribution Channel
6.1. Introduction
6.2. Global Dengue Vaccine Revenue and Market Share by Distribution Channel (2017-2027)
6.2.1. Global Dengue Vaccine Revenue and Revenue Share by Distribution Channel (2017-2027)
6.3. Online Pharmacies
6.3.1. Global Online Pharmacies Revenue and Growth Rate (2017-2027)
6.4. Hospital Pharmacies
6.4.1. Global Hospital Pharmacies Revenue and Growth Rate (2017-2027)
6.5. Drug Store
6.5.1. Global Drug Store Revenue and Growth Rate (2017-2027)
6.6. Retail Pharmacies
6.6.1. Global Retail Pharmacies Revenue and Growth Rate (2017-2027)
6.7. Other Distribution Channels
6.7.1. Global Other Distribution Channels Revenue and Growth Rate (2017-2027)
7. Dengue Vaccine Market, By Region
7.1. Introduction
7.2. Global Dengue Vaccine Revenue and Market Share by Regions
7.2.1. Global Dengue Vaccine Revenue by Regions (2017-2027)
7.3. North America Dengue Vaccine by Countries
7.3.1. North America Dengue Vaccine Revenue and Growth Rate (2017-2027)
7.3.2. North America Dengue Vaccine Revenue (Million USD) by Countries (2017-2027)
7.3.3. United States
7.3.3.1. United States Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.4. Canada
7.3.4.1. Canada Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.3.5. Mexico
7.3.5.1. Mexico Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4. Europe Dengue Vaccine by Countries
7.4.1. Europe Dengue Vaccine Revenue and Growth Rate (2017-2027)
7.4.2. Europe Dengue Vaccine Revenue (Million USD) by Countries (2017-2027)
7.4.3. Germany
7.4.3.1. Germany Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.4. France
7.4.4.1. France Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.5. UK
7.4.5.1. UK Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.6. Russia
7.4.6.1. Russia Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.7. Italy
7.4.7.1. Italy Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.4.8. Rest of Europe
7.4.8.1. Rest of Europe Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5. Asia-Pacific Dengue Vaccine by Countries
7.5.1. Asia-Pacific Dengue Vaccine Revenue and Growth Rate (2017-2027)
7.5.2. Asia-Pacific Dengue Vaccine Revenue (Million USD) by Countries (2017-2027)
7.5.3. China
7.5.3.1. China Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.4. Japan
7.5.4.1. Japan Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.5. Korea
7.5.5.1. Korea Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.6. India
7.5.6.1. India Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.7. Southeast Asia
7.5.7.1. Southeast Asia Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.5.8. Rest of Asia-Pacific
7.5.8.1. Rest of Asia-Pacific Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.6. South America Dengue Vaccine by Countries
7.6.1. South America Dengue Vaccine Revenue and Growth Rate (2017-2027)
7.6.2. South America Dengue Vaccine Revenue (Million USD) by Countries (2017-2027)
7.6.3. Brazil
7.6.3.1. Brazil Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.4. Argentina
7.6.4.1. Argentina Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.5. Columbia
7.6.5.1. Columbia Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.6.6. Rest of South America
7.6.6.1. Rest of South America Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7. Middle East and Africa Dengue Vaccine by Countries
7.7.1. Middle East and Africa Dengue Vaccine Revenue and Growth Rate (2017-2027)
7.7.2. Middle East and Africa Dengue Vaccine Revenue (Million USD) by Countries (2017-2027)
7.7.3. Saudi Arabia
7.7.3.1. Saudi Arabia Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.4. United Arab Emirates
7.7.4.1. United Arab Emirates Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.5. Egypt
7.7.5.1. Egypt Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.6. Nigeria
7.7.6.1. Nigeria Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.7. South Africa
7.7.7.1. South Africa Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.8. Turkey
7.7.8.1. Turkey Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
7.7.9. Rest of Middle East and Africa
7.7.9.1. Rest of Middle East and Africa Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
8. Company Profiles
8.1. Takeda Pharmaceutical Company Ltd.
8.1.1. Business Overview
8.1.2. Service Portfolio
8.1.3. Strategic Developments
8.1.4. Financial Overview
8.2. Sanofi Pasteur
8.2.1. Business Overview
8.2.2. Service Portfolio
8.2.3. Strategic Developments
8.2.4. Financial Overview
8.3. Merck & Co., Inc.
8.3.1. Business Overview
8.3.2. Service Portfolio
8.3.3. Strategic Developments
8.3.4. Financial Overview
8.4. Panacea Biotec
8.4.1. Business Overview
8.4.2. Service Portfolio
8.4.3. Strategic Developments
8.4.4. Financial Overview
8.5. GlaxoSmithKline plc
8.5.1. Business Overview
8.5.2. Service Portfolio
8.5.3. Strategic Developments
8.5.4. Financial Overview
8.6. Biological E. Limited
8.6.1. Business Overview
8.6.2. Service Portfolio
8.6.3. Strategic Developments
8.6.4. Financial Overview
9. Dengue Vaccine Market Forecast (2017-2027)
9.1. Global Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2027)
9.2. Dengue Vaccine Market Forecast by Regions (2017-2027)
9.2.1. North America Dengue Vaccine Market Forecast (2017-2027)
9.2.1.1. United States Dengue Vaccine Market Forecast (2017-2027)
9.2.1.2. Canada Dengue Vaccine Market Forecast (2017-2027)
9.2.1.3. Mexico Dengue Vaccine Market Forecast (2017-2027)
9.2.2. Europe Dengue Vaccine Market Forecast (2017-2027)
9.2.2.1. Germany Dengue Vaccine Market Forecast (2017-2027)
9.2.2.2. France Dengue Vaccine Market Forecast (2017-2027)
9.2.2.3. UK Dengue Vaccine Market Forecast (2017-2027)
9.2.2.4. Russia Dengue Vaccine Market Forecast (2017-2027)
9.2.2.5. Italy Dengue Vaccine Market Forecast (2017-2027)
9.2.2.6. Rest of Europe Dengue Vaccine Market Forecast (2017-2027)
9.2.3. Asia-Pacific Dengue Vaccine Market Forecast (2017-2027)
9.2.3.1. China Dengue Vaccine Market Forecast (2017-2027)
9.2.3.2. Japan Dengue Vaccine Market Forecast (2017-2027)
9.2.3.3. Korea Dengue Vaccine Market Forecast (2017-2027)
9.2.3.4. India Dengue Vaccine Market Forecast (2017-2027)
9.2.3.5. Southeast Asia Dengue Vaccine Market Forecast (2017-2027)
9.2.3.6. Rest of Asia-Pacific Dengue Vaccine Market Forecast (2017-2027)
9.2.4. South America Dengue Vaccine Market Forecast (2017-2027)
9.2.4.1. Brazil Dengue Vaccine Market Forecast (2017-2027)
9.2.4.2. Argentina Dengue Vaccine Market Forecast (2017-2027)
9.2.4.3. Columbia Dengue Vaccine Market Forecast (2017-2027)
9.2.4.4. Rest of South America Dengue Vaccine Market Forecast (2017-2027)
9.2.5. Middle East and Africa Dengue Vaccine Market Forecast (2017-2027)
9.2.5.1. Saudi Arabia Dengue Vaccine Market Forecast (2017-2027)
9.2.5.2. United Arab Emirates Dengue Vaccine Market Forecast (2017-2027)
9.2.5.3. Egypt Dengue Vaccine Market Forecast (2017-2027)
9.2.5.4. Nigeria Dengue Vaccine Market Forecast (2017-2027)
9.2.5.5. South Africa Dengue Vaccine Market Forecast (2017-2027)
9.2.5.6. Turkey Dengue Vaccine Market Forecast (2017-2027)
9.2.5.7. Rest of Middle East and Africa Dengue Vaccine Market Forecast (2017-2027)
9.3. Dengue Vaccine Market Forecast by Product (2017-2027)
9.3.1. Dengue Vaccine Forecast by Product (2017-2027)
9.3.2. Dengue Vaccine Market Share Forecast by Product (2017-2027)
9.4. Dengue Vaccine Market Forecast by Distribution Channel (2017-2027)
9.4.1. Dengue Vaccine Forecast by Distribution Channel (2017-2027)
9.4.2. Dengue Vaccine Market Share Forecast by Distribution Channel (2017-2027)
List of Tables
List of Tables and Figures:
Figure United States Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Dengue Vaccine Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Dengue Vaccine Revenue and Revenue Share by Product (2017-2018)
Figure Global CYD-TDV (Dengvaxia) Revenue and Growth Rate (2017-2018)
Table Global Dengue Vaccine Revenue and Revenue Share by Distribution Channel (2017-2018)
Figure Global Online Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Hospital Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Drug Store Revenue and Growth Rate (2017-2018)
Figure Global Retail Pharmacies Revenue and Growth Rate (2017-2018)
Figure Global Other Distribution Channels Revenue and Growth Rate (2017-2018)
Table Global Dengue Vaccine Revenue by Regions (2017-2018)
Figure North America Dengue Vaccine Growth Rate (2017-2018)
Figure North America Dengue Vaccine Revenue and Growth Rate (2017-2018)
Figure North America Dengue Vaccine by Countries (2017-2018)
Figure North America Dengue Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure United States Dengue Vaccine Growth Rate (2017-2018)
Figure United States Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Dengue Vaccine Growth Rate (2017-2018)
Figure Canada Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Dengue Vaccine Growth Rate (2017-2018)
Figure Mexico Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Dengue Vaccine Growth Rate (2017-2018)
Figure Europe Dengue Vaccine Revenue and Growth Rate (2017-2018)
Figure Europe Dengue Vaccine by Countries (2017-2018)
Figure Europe Dengue Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure Germany Dengue Vaccine Growth Rate (2017-2018)
Figure Germany Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Dengue Vaccine Growth Rate (2017-2018)
Figure France Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Dengue Vaccine Growth Rate (2017-2018)
Figure UK Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Dengue Vaccine Growth Rate (2017-2018)
Figure Russia Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Dengue Vaccine Growth Rate (2017-2018)
Figure Italy Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Dengue Vaccine Growth Rate (2017-2018)
Figure Rest of Europe Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Dengue Vaccine Growth Rate (2017-2018)
Figure Asia-Pacific Dengue Vaccine Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Dengue Vaccine by Countries (2017-2018)
Figure Asia-Pacific Dengue Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure China Dengue Vaccine Growth Rate (2017-2018)
Figure China Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Dengue Vaccine Growth Rate (2017-2018)
Figure Japan Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Dengue Vaccine Growth Rate (2017-2018)
Figure Korea Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Dengue Vaccine Growth Rate (2017-2018)
Figure India Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Dengue Vaccine Growth Rate (2017-2018)
Figure Southeast Asia Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Dengue Vaccine Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Dengue Vaccine Growth Rate (2017-2018)
Figure South America Dengue Vaccine Revenue and Growth Rate (2017-2018)
Figure South America Dengue Vaccine by Countries (2017-2018)
Figure South America Dengue Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Dengue Vaccine Growth Rate (2017-2018)
Figure Brazil Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Dengue Vaccine Growth Rate (2017-2018)
Figure Argentina Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Dengue Vaccine Growth Rate (2017-2018)
Figure Columbia Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Dengue Vaccine Growth Rate (2017-2018)
Figure Rest of South America Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Dengue Vaccine Growth Rate (2017-2018)
Figure Middle East and Africa Dengue Vaccine Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Dengue Vaccine by Countries (2017-2018)
Figure Middle East and Africa Dengue Vaccine Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Dengue Vaccine Growth Rate (2017-2018)
Figure Saudi Arabia Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Dengue Vaccine Growth Rate (2017-2018)
Figure United Arab Emirates Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Dengue Vaccine Growth Rate (2017-2018)
Figure Egypt Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Dengue Vaccine Growth Rate (2017-2018)
Figure Nigeria Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Dengue Vaccine Growth Rate (2017-2018)
Figure South Africa Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Dengue Vaccine Growth Rate (2017-2018)
Figure Turkey Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Dengue Vaccine Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Dengue Vaccine Revenue (Millions USD) and Growth Rate (2017-2018)
Table Takeda Pharmaceutical Company Ltd. Dengue Vaccine Financial Overview
Table Sanofi Pasteur Dengue Vaccine Financial Overview
Table Merck & Co., Inc. Dengue Vaccine Financial Overview
Table Panacea Biotec Dengue Vaccine Financial Overview
Table GlaxoSmithKline plc Dengue Vaccine Financial Overview
Table Biological E. Limited Dengue Vaccine Financial Overview
Figure Global Dengue Vaccine Revenue (Millions USD) and Growth Rate (2018-2025)
Table Dengue Vaccine Market Forecast by Regions (2018-2025)
Figure North America Dengue Vaccine Market Forecast (2018-2025)
Figure United States Dengue Vaccine Market Forecast (2018-2025)
Figure Canada Dengue Vaccine Market Forecast (2018-2025)
Figure Mexico Dengue Vaccine Market Forecast (2018-2025)
Figure Europe Dengue Vaccine Market Forecast (2018-2025)
Figure Germany Dengue Vaccine Market Forecast (2018-2025)
Figure France Dengue Vaccine Market Forecast (2018-2025)
Figure UK Dengue Vaccine Market Forecast (2018-2025)
Figure Russia Dengue Vaccine Market Forecast (2018-2025)
Figure Italy Dengue Vaccine Market Forecast (2018-2025)
Figure Rest of Europe Dengue Vaccine Market Forecast (2018-2025)
Figure Asia-Pacific Dengue Vaccine Market Forecast (2018-2025)
Figure China Dengue Vaccine Market Forecast (2018-2025)
Figure Japan Dengue Vaccine Market Forecast (2018-2025)
Figure Korea Dengue Vaccine Market Forecast (2018-2025)
Figure India Dengue Vaccine Market Forecast (2018-2025)
Figure Southeast Asia Dengue Vaccine Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Dengue Vaccine Market Forecast (2018-2025)
Figure South America Dengue Vaccine Market Forecast (2018-2025)
Figure Brazil Dengue Vaccine Market Forecast (2018-2025)
Figure Argentina Dengue Vaccine Market Forecast (2018-2025)
Figure Columbia Dengue Vaccine Market Forecast (2018-2025)
Figure Rest of South America Dengue Vaccine Market Forecast (2018-2025)
Figure Middle East and Africa Dengue Vaccine Market Forecast (2018-2025)
Figure Saudi Arabia Dengue Vaccine Market Forecast (2018-2025)
Figure United Arab Emirates Dengue Vaccine Market Forecast (2018-2025)
Figure Egypt Dengue Vaccine Market Forecast (2018-2025)
Figure Nigeria Dengue Vaccine Market Forecast (2018-2025)
Figure South Africa Dengue Vaccine Market Forecast (2018-2025)
Figure Turkey Dengue Vaccine Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Dengue Vaccine Market Forecast (2018-2025)
Figure Global Dengue Vaccine Forecast by Product (2018-2025)
Figure Global Dengue Vaccine Market Share Forecast by Product (2018-2025)
Figure Global Dengue Vaccine Forecast by Product (2018-2025)
Figure Global Dengue Vaccine Forecast by Distribution Channel (2018-2025)
Figure Global Dengue Vaccine Market Share Forecast by Distribution Channel (2018-2025)
Figure Global Dengue Vaccine Forecast by Distribution Channel (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|